Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

149.96
Delayed Data
As of Sep 03
 -3.79 / -2.47%
Today’s Change
110.12
Today|||52-Week Range
190.29
+15.81%
Year-to-Date

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 175.00, with a high estimate of 244.00 and a low estimate of 92.00. The median estimate represents a +16.70% increase from the last price of 149.96.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in United Therapeutics Corp. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.36
Sales
$364.3M
Reporting Date
Oct 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 23.46%
 
 
 
 
 
 
Growthannually 13.59%
 
 
 
 
 
 

Sales

Growthquarterly 4.94%
 
 
 
 
 
 
Growthannually 10.38%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.